Bamco Inc Glaukos Corp Transaction History
Bamco Inc
- $36.8 Billion
- Q3 2024
A detailed history of Bamco Inc transactions in Glaukos Corp stock. As of the latest transaction made, Bamco Inc holds 20,000 shares of GKOS stock, worth $2.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$2.9 Million
Previous $2.37 Million
10.05%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
342Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$852 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$317 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$284 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$238 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.91B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...